“The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.” Listen to the newscast here.
Source: Listen: How AI, Data Are Boosting FDA’s Regulatory Processes – September 9, 2021. GovernmentCIO.
